Nazary Kefayatullah, Hussain Nabeel, Ojo Roland Oluwapelumi, Anwar Sana, Kadurei Firas, Hafizyar Farukhzad, Muhammad Haroon Daniya, Khemani Rakesh, Talpur Abdul Subhan
Internal Medicine, Kabul University of Medical Sciences, Kabul, AFG.
Internal Medicine, Saba University School of Medicine, Devens, USA.
Cureus. 2021 Sep 23;13(9):e18204. doi: 10.7759/cureus.18204. eCollection 2021 Sep.
Rheumatoid arthritis (RA) is associated with various autoimmune disorders, including thyroid dysfunction. However, local data studying the prevalence of thyroid dysfunction in newly diagnosed RA patients are limited.
This case-control study was conducted between January 2019 to December 2020 in the Internal Medicine Department of Liaquat University of Medical and Health Sciences. The study group of 400 newly diagnosed patients with RA was enrolled in the study. Another 400 patients without the diagnosis of RA, adjusted for age and gender, were enrolled in the study as a control group and their thyroid functions were compared.
Patients with RA had more participants with thyroid dysfunction compared to patients without RA (25.25% vs. 11.5%; p-value: 0.00001). In addition, more patients with RA had concomitant primary hypothyroidism compared to the control group (7.75% vs. 2.5%; p-value: 0.0007). Furthermore, patients with RA also had a higher prevalence of subclinical hypothyroidism (13.0% vs. 5.5%; p-value: 0.0002).
Our study indicates that thyroid dysfunction is significantly prevalent in patients with RA. Based on our findings, it is suggested that management and follow-up of RA patients should include the screening of thyroid auto-antibodies and thyroid dysfunction.
类风湿性关节炎(RA)与包括甲状腺功能障碍在内的多种自身免疫性疾病相关。然而,关于新诊断的RA患者中甲状腺功能障碍患病率的本地数据有限。
本病例对照研究于2019年1月至2020年12月在利亚卡特医科和健康科学大学内科进行。400名新诊断的RA患者被纳入研究组。另外400名未诊断为RA的患者,根据年龄和性别进行调整后,作为对照组纳入研究,并比较他们的甲状腺功能。
与无RA的患者相比,RA患者中甲状腺功能障碍的参与者更多(25.25%对11.5%;p值:0.00001)。此外,与对照组相比,更多的RA患者伴有原发性甲状腺功能减退(7.75%对2.5%;p值:0.0007)。此外,RA患者亚临床甲状腺功能减退的患病率也更高(13.0%对5.5%;p值:0.0002)。
我们的研究表明,甲状腺功能障碍在RA患者中显著普遍。基于我们的研究结果,建议对RA患者的管理和随访应包括甲状腺自身抗体和甲状腺功能障碍的筛查。